How High Potency Trends Influence Quality Judgments and Purchasing Power

Grow operations spend months, sometimes years, dialing in a strain. They fine-tune growing conditions, timing, aroma, and every other detail until they finally produce a batch they’re proud to put their name on. After all that hard work, they prepare to bring their product to market and submit it for cannabis lab testing.

The THC result: 24%.

Let’s imagine that’s a strong result for this particular strain. Some old-school genetics don’t even break 20%. However, this grow operation typically produces flower ranging from 25–30% THC. Suddenly, that 24% batch sits at the bottom of its potency lineup, and that presents a problem.

When buyers review the brand’s available strains, they might overlook this particular flower entirely. In fact, they might not even notice it. THC carries so much weight in purchasing decisions that buyers can easily glance past the bottom half of a dozen available strains. Just like that, months of hard work and careful cultivation amount to nothing.

For many grow operations, the goal becomes simple: achieve a THC percentage high enough to keep buyers interested. Miss that cutoff, and the conversation ends before anyone even sees the cannabis.

That puts growers in a frustrating position. What happens to the unique strains they believe in? Should they abandon those genetics and grow something more likely to produce higher THC numbers? High-potency dessert strains already saturate the market. That’s often why cultivators pursue something different in the first place.

When THC percentages determine which products get a chance, they also influence which strains growers choose to cultivate. Over time, that pressure threatens the very diversity that makes cannabis interesting. Different names on the jars, but more and more of the same thing inside.

And that’s the frustration: growers spend months perfecting something unique, only for buyers to dismiss it because the number isn’t high enough.

But what does that number actually tell buyers about the flower they just passed over?

That’s where the research gets interesting. There’s much more to the cannabis experience than a THC percentage can explain.

The takeaway: Focusing too heavily on THC percentages can prevent growers from communicating what makes their products unique.

A Bigger Number Does Not Deliver a Bigger Experience

Think about some of the most memorable flower you’ve smoked. What made those experiences stand out?

Maybe it was the flavor, the unique (and sometimes potent) high, or simply how the experience made you feel. Those qualities often had little to do with THC content.

Other chemical compounds clearly contributed to those experiences. Many of us remember strains that delivered profound effects despite having what today’s market would consider modest THC percentages. For some, those experiences even remind us why we started consuming cannabis in the first place.

In fact, strains outside the popular dessert and OG profiles can produce THC results in the 10–20% range. As growers explore genetics that differ from today’s dominant offerings, they may encounter strains with THC percentages that buyers consider too low.

The 2022 study The Nose Knows approached this question from another direction.

Researchers analyzed 3,063 consumption-session surveys from 276 people evaluating Oregon competition flower. They found that participants associated pleasant aromas with greater subjective appeal. THC potency and total terpene concentration, however, showed no such association. These findings highlight two important points. First, THC alone cannot predict how much someone will enjoy a particular strain. Second, cannabis likely contains additional quality markers that THC and terpene measurements alone cannot fully capture.

Of course, that doesn’t mean our noses can perfectly predict cannabis quality. Competition entries and self-reported experiences cannot establish which compounds cause particular effects. Still, the research gives buyers a reason to keep an open mind. Our own experiences reinforce that point: a THC percentage cannot fully explain what makes cannabis enjoyable.

Equating higher THC with better cannabis creates a misleading comparison.

The takeaway: THC percentages describe certain aspects of a plant’s chemistry, but they cannot predict how much someone will enjoy the flower.

Something Different, as Long as It Tests the Same…

So where does that leave grow operations trying to bring something different to market?

They could abandon their unique genetics, shift toward the same strains everyone else grows, and join the endless competition to offer 1% more THC for $1 less.

Or they could continue searching for flower that smells, tastes, and smokes differently while still trying to meet the same THC expectations as every other product on the menu.

That second option sounds reasonable, but finding exceptional genetics takes time, space, and repeated evaluations.

When growers add strict THC cutoffs to their selection criteria, they may reject strains they would otherwise love to release. How much room does that leave for something genuinely different? As a sidenote, this author’s favorite strain is Bubba Kush, which can come in at around 10% THC.

A higher-testing strain doesn’t automatically replace what makes Bubba Kush a personal favorite. That’s an important part of purchasing behavior we often overlook: consumers develop preferences that potency rankings simply cannot explain. Concerns about disappearing genetics already exist throughout the regulated cannabis market.

CANNA’s recap of a 2025 genetics panel, which included California cultivator Kevin Jodrey, described how some legacy cultivars survive only outside the regulated market because of regulatory and operational pressures. That observation doesn’t identify THC expectations as the sole cause. However, it highlights a concerning outcome: these genetics still exist, but consumers shopping within the regulated market may never encounter them.

THC-first purchasing practices can intensify this problem.

When buyers consistently prioritize the same potency requirements, they narrow the selection before customers even see the available products. Growers then struggle to differentiate their brands in an increasingly crowded market, relying on the same THC percentages that helped create the oversaturation.

The takeaway: When buyers expect every strain to meet the same THC requirements, growers face pressure to compete on numbers rather than the qualities that make their flower worth choosing.

Why Do Businesses Keep Chasing the Number?

It’s easy to blame buyers, but they have sales goals to meet, too.

Headset’s 2025 analysis found that California flower marketed at 28–30% THC sold more units than flower marketed at 25–27%, even though the higher-potency category offered fewer distinct products. These figures reflect marketed THC percentages recorded through retail sales systems, not independently verified laboratory measurements.

Still, the data helps explain why businesses prioritize high-THC products. Consumers want them, retailers have a reason to stock them, and growers cannot ignore that demand while trying to keep their operations profitable.

But there’s a difference between carrying products because customers want them and automatically dismissing everything else.

When buyers make THC percentages a requirement for consideration, that pressure doesn’t stop with cultivation. It follows the product into the testing laboratory.

The takeaway: High-THC products can sell well, but their success doesn’t tell us how other products might perform if buyers gave them a fair opportunity.

When the Result Becomes the Product

Cannabis laboratories test flower to determine its chemical composition. That process should provide straightforward, accurate information.

However, when a few percentage points determine whether buyers even consider a strain, an accurate laboratory result can quickly become an unwelcome one. California’s Department of Cannabis Control addresses this problem in its proposed 2026 track-and-trace changes.

The department identifies “lab shopping” as a practice in which businesses submit samples from the same batch to multiple laboratories and select the most favorable results, including the highest THC percentage.

The DCC also warns that potency inflation and lab shopping harm honest operators and mislead consumers. This issue extends far beyond one disappointing Certificate of Analysis (COA).

When the market rewards businesses for finding the highest possible result, laboratories that report accurate numbers can lose their competitive advantage. Growers who accept those results and market their products honestly can face the same disadvantage.

Research outside California reinforces the importance of testing accuracy. A 2025 study examined 277 cannabis products from 52 Colorado dispensaries. Researchers found that 56.7% of flower products met the study’s accuracy threshold of ±15% of labeled THC, compared with 96% of concentrates.

Those discrepancies don’t necessarily indicate deliberate misconduct. Sampling methods, flower variability, and analytical differences can also contribute to inconsistent results. Nevertheless, the findings demonstrate why independent verification of THC label claims matters.

Cannabis laboratories have a responsibility to provide accurate, defensible results. Sometimes that means reporting a lower THC percentage than a client hoped to receive. But laboratory results must remain credible and useful, even when they don’t support a product’s sales goals.

The takeaway: Accurate results should never put laboratories or honest growers at a competitive disadvantage. Rewarding inflated potency numbers does exactly that.

Could This Also Affect What People Spend?

When customers browse a dispensary menu and see little difference between products, what encourages them to explore?

Why should they try another strain? What makes a second product worth adding to their purchase?

Dispensaries should consider these questions, especially when looking for ways to encourage repeat visits and increase customer engagement.

A limited selection could discourage customers from exploring new products. However, current evidence doesn’t establish that declining strain diversity directly causes smaller shopping baskets.

California’s DCC reported that falling prices drove declining retail sales value in 2024, even as consumption and production continued to increase.

That distinction matters.

Still, the industry has an opportunity to explore whether greater product diversity can influence purchasing behavior. Could dispensaries encourage customers to try something new by offering a wider range of strains and explaining what makes each one different? Retailers could test that idea by tracking whether customers add these products to purchases alongside high-THC flower. They could also measure changes in basket value, product margins, and repeat purchases.

The concept has commercial potential, but retailers need real-world data to determine whether it works.

The takeaway: A more interesting product selection could give customers another reason to buy. Retailers can measure whether that variety translates into increased spending.

Giving Something Different a Chance

Dispensaries should continue marketing high-potency strains, and growers should continue producing them.

After all, diversity is the proverbial battle cry, and high-THC flower deserves its place in the market. But the industry should also make room for a smorgasbord of flower that offers something THC percentages alone cannot describe.

For buyers, that starts with reconsidering automatic potency cutoffs. Before passing over a strain, ask what made the grower keep it in the first place.

What makes it different? What feedback have customers shared? Could this particular flower appeal to someone looking for a different experience?

Consumers can also look beyond potency when making purchasing decisions.

Ask budtenders when the flower was harvested and packaged, how the dispensary stores it, and why they recommend it. Share what you enjoyed about previous purchases. Those conversations give budtenders an opportunity to recommend products based on more than a THC percentage.

Growers can support these decisions by sharing clear batch information and meaningful descriptions of their genetics.

Laboratories contribute by providing credible cannabis testing results that businesses and consumers can trust.

Dispensaries can empower their staff to explain what makes each product worth carrying.

If the industry’s goal is to offer premier cannabis, we should be able to explain what makes a product worth buying.

Potency plays a role, but so do the characteristics that motivated a grower to spend months perfecting a strain in the first place.

That 24% flower might be exactly what a customer wants.

A THC percentage alone shouldn’t end the conversation before they have a chance to discover it.

The takeaway: Give buyers more to evaluate, customers more to discover, and growers more reasons to keep unique genetics in their operations.